Ironwood Pharmaceuticals (IRWD) Return on Sales (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Return on Sales across 17 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.0%, up 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q1 2026 at Ironwood Pharmaceuticals, up from 0.03% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2022 to a low of 0.1% in Q2 2023.
• The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.01%.
• Across the five-year window, Return on Sales slipped 11 bps in 2023 and climbed 10 bps in 2024, its largest moves.
• Ironwood Pharmaceuticals' Return on Sales stood at 0.0% in 2022, then slumped by 526 bps to 0.02% in 2023, then soared by 45 bps to 0.01% in 2024, then tumbled by 141 bps to 0.03% in 2025, then soared by 115 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.03% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.